U.S. Biotech Stock News

Earlier this week, Beam Therapeutics reported updated Phase 1/2 data for its in vivo base-editing therapy BEAM-302 in alpha-1 antitrypsin deficiency, selecting a 60 mg dose to advance into pivotal development under a potential FDA accelerated approval pathway. The data highlight rapid, durable biomarker changes consistent with direct genetic correction in both lung and liver disease patients, underscoring BEAM-302’s potential as a one-time, base-editing treatment approach. We’ll now explore...

Event context and recent performance Delek Logistics Partners (DKL) has drawn investor attention after recent trading saw a 1.9% decline in the latest session, following a period where the unit price has moved higher over the past 3 months and year. See our latest analysis for Delek Logistics Partners. While the latest 1.9% daily share price decline to US$53.12 has cooled near term sentiment, the 90 day share price return of 18.44% and 1 year total shareholder return of 34.55% suggest...

Recent analysis of Ducommun (DCO) has focused on a declining backlog, shrinking operating margins, and breakeven free cash flow. These factors appear to have shaped sentiment around the stock’s latest move. See our latest analysis for Ducommun. The share price has eased in the very short term, with a 1 month share price return of 4.73% and a 1 day move of 0.53%. However, the 90 day share price return of 25.21% and 1 year total shareholder return of 106.57% point to momentum building over a...

International Seaways recently disclosed that Chief Accounting Officer James D. Small III sold 20,000 shares of common stock for roughly US$1.5 million, following a period of strong operational performance and a record quarterly dividend. This sale, the largest proportion of his holdings he has disposed of in a single transaction, comes as the company highlights its best quarter since early 2024, ongoing fleet renewal, lower net loan-to-value, and fresh bond issuance. Next, we’ll examine how...

Setting Up The Valuation Picture For AXIS Capital Holdings AXIS Capital Holdings might be on your radar if you are asking whether the current share price lines up with the underlying value of the business, and this article is built to help you answer exactly that question. At a last close of US$98.91, the stock has seen a 0.7% return over the last 7 days, a 3.6% decline over 30 days, a 5.1% decline year to date, a 1.1% return over 1 year, and very large gains of 93.7% over 3 years and 122.0%...

Fox (FOXA) is back in focus after its streaming platform Tubi announced a broad set of ad tech upgrades, interactive formats and high profile content partnerships at the IAB NewFronts in New York. See our latest analysis for Fox. At a share price of US$59.11, Fox has seen a 9.22% 1 month share price return but a 19.86% share price decline year to date. Its 1 year total shareholder return of 9.03% and 3 year total shareholder return of 80.30% suggest longer term holders have experienced much...

What recent performance says about Plains All American Pipeline Plains All American Pipeline (PAA) has caught investor attention after a 0.4% decline over the past day, alongside gains of 3.6% for the week and about 9.7% over the past month. Those moves sit on top of a roughly 27.1% return over the past 3 months and about 23.2% year to date. The units closed at US$22.44, with a market value near US$15.9b. See our latest analysis for Plains All American Pipeline. For PAA, the recent 1 month...

Rogers (NYSE:ROG) recently reported that annual sales have declined by 5.5% for two consecutive years, while rising costs have reduced its operating margin by 7.2 percentage points, pressuring profitability across its engineered materials portfolio. This combination of falling revenue and shrinking margins has raised concerns that the company’s products are not fully aligning with current demand in electric vehicles, telecommunications, and other high‑performance applications. We’ll now...

On March 20, 2026, JPMorgan upgraded Air Products and Chemicals to Overweight, citing the company’s resilient earnings profile despite macroeconomic pressures and benefits from tightening helium supply. The upgrade also underscored how rising helium prices, driven by geopolitical supply constraints, could support Air Products’ gas portfolio alongside its refinery-linked businesses. We’ll now examine how JPMorgan’s helium-focused rationale fits with Air Products’ existing investment narrative...

For readers wondering whether AAR at US$107.25 is still priced fairly after a strong run, or if the value case is already reflected in the price, this article walks through the numbers so you can assess the valuation with more confidence. The stock shows a mixed short-term picture, with a 5.8% return over the past week, an 8.4% decline over the last 30 days, a 27.0% year-to-date return, and an 87.7% return over the past year. Those moves sit against a longer backdrop in which the shares have...

GXO Logistics (GXO) is back in focus after opening Hasbro’s 600,000 square foot, AI powered distribution center in Midway, Georgia, and rolling out an autonomous industrial truck pilot in France. See our latest analysis for GXO Logistics. Even with headlines around AI powered warehouses and autonomous trucks, GXO’s share price has had a 22.18% decline over the past month and an 8.58% year to date share price decline. The 1 year total shareholder return is 26.25%, which hints that longer term...

Veritone (VERI) has drawn fresh attention after announcing a multi-year agreement with Oracle to move its AI solutions, including aiWARE, Veritone Data Refinery, and Veritone Data Marketplace, onto Oracle Cloud Infrastructure. See our latest analysis for Veritone. The Oracle agreement and recent product updates arrive after a steep reset in expectations, with the share price down 61.6% year to date and a 5 year total shareholder return decline of 92.5%, pointing to fading momentum as...

Reddit (RDDT) is back in focus after a Los Angeles jury held Meta and Alphabet liable for social media addiction harms, a ruling that has sharpened investor attention on Reddit’s potential legal and regulatory exposure. See our latest analysis for Reddit. At a share price of $121.84, Reddit has seen a 1 day share price return of 4.26% decline and a 90 day share price return of 46.03% decline, even as the 1 year total shareholder return sits at 13.12%. Recent legal headlines and executive...

Automatic Data Processing (ADP) is back in focus after its ADP Research arm released the Today at Work 2026, Issue 1 report, which highlights widespread worker anxiety about job security as employers adopt AI and adjust to demographic change. See our latest analysis for Automatic Data Processing. Despite spotlight-grabbing research on AI and worker anxiety and an upcoming quarterly earnings release on April 29, the share price has lost momentum. The 90-day share price return of 22.25% and the...

Anthropic is reportedly testing a new Claude Mythos AI model with advanced cybersecurity and reasoning abilities that could challenge traditional platforms. Leaked documents suggest Claude Mythos may offer AI native defense and offense tools that change how enterprises detect and respond to cyber threats. These reports arrive as investors reassess exposure to established cybersecurity vendors such as Palo Alto Networks, ticker NasdaqGS:PANW. Palo Alto Networks enters this news cycle with a...

Shareholder John Chevedden has filed a proposal at Dover Corporation (NYSE: DOV) calling for an independent board chairman. The proposal seeks a formal policy that the roles of Chairman and CEO be held by different individuals. Dover's board has recommended that shareholders vote against the proposal at the upcoming annual general meeting. Dover, traded on the NYSE under the ticker DOV, operates as a diversified industrial company with exposure to equipment, components, and related...

ANI Pharmaceuticals recently reported record 2025 revenue of US$883.4 million, driven largely by strong growth in its Rare Disease segment and Cortrophin Gel, while an executive share sale on March 11, 2026 drew investor attention. The company’s guidance for more than US$1.00 billion in 2026 revenue highlights how Rare Disease therapies are becoming an increasingly central pillar of its business model. We’ll now examine how ANI Pharmaceuticals’ push past US$1.00 billion in guided 2026...

Attention around Oscar Health (OSCR) is building ahead of its forthcoming earnings release, where projections point to a significantly higher EPS than a year ago, set alongside expanding margins and rising operational efficiency. See our latest analysis for Oscar Health. Despite the upcoming earnings focus, recent trading has been weak, with a 30 day share price return showing a decline of 13.98% and a year to date share price return showing a decline of 25.58%, while the 3 year total...

In March 2026, Constellation Energy filed a definitive proxy urging shareholders to vote against a DEI-related proposal and registered up to 50,000,000 common shares, worth about US$15.86 billion, for an ESOP-related shelf offering. These moves come as Constellation deepens nuclear-focused partnerships with major technology companies and reshapes its generation portfolio following the Calpine acquisition and planned PJM asset sales. We’ll now examine how Constellation’s expanded nuclear...

SELLAS Life Sciences Group (SLS) is drawing attention after releasing preclinical data on its CDK9 inhibitor SLS009 in acute myeloid leukemia and filing both a universal shelf registration and a US$150 million at-the-market equity offering. See our latest analysis for SELLAS Life Sciences Group. Those preclinical SLS009 data and the fresh shelf and at the market filing are landing after a sharp run, with the 1 year total shareholder return near 3x and a 52.09% 90 day share price return, even...

If you are wondering whether Norwegian Cruise Line Holdings at around US$18.49 is a bargain or a value trap, this breakdown is designed to help you frame that question clearly. The stock has fallen 2.4% over the last week, 22.3% over the last month, 18.8% year to date and 3.4% over the last year, even though the three year return sits at 37.5% and the five year return at a 33.3% decline. Recent headlines have focused on the broader cruise and travel sector, with investors weighing changing...

ITT (ITT) has drawn fresh interest after recent share price swings, including an 11.6% decline over the past month and a 3.8% gain over the past 3 months, prompting closer attention to its current valuation. See our latest analysis for ITT. The recent 1-month share price return of negative 11.6% contrasts with a 6% year to date share price gain and a 1-year total shareholder return of 44.7%. This suggests that longer term momentum remains stronger than the latest pullback. If ITT’s moves have...

DLocal Limited reported past fourth-quarter and full-year 2025 results with higher sales and net income, issued 2026 operating profit growth guidance of 27.5%–32.5% year-over-year, and declared a cash dividend totaling about US$57,211,274, or roughly US$0.1939 per share, payable in June 2026. The combination of stronger profitability metrics, forward-looking profit guidance, and a sizable cash return to shareholders highlights management’s confidence in DLocal’s current earnings power and...

Karman Holdings Inc. recently reported past fourth-quarter 2025 results showing sales of US$134.49 million and net income of US$7.71 million, with full-year 2025 sales reaching US$471.50 million and net income of US$17.37 million. The company also raised its 2026 revenue outlook to US$715 million–US$730 million as its funded backlog moved beyond US$1 billion and recent acquisitions broadened its space and defense capabilities. Now, we’ll examine how the raised 2026 revenue guidance and...